Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antirheumatic Agents”

Showing 20 of 0 results

Not applicableStudy completedNCT01083693
What this trial is testing

Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis
Abbott 162
Not applicableStudy completedNCT03073109
What this trial is testing

Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions

Who this might be right for
Arthritis, Rheumatoid
Pfizer 170
Large-scale testing (Phase 3)Ended earlyNCT02930343
What this trial is testing

Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy

Who this might be right for
Rheumatoid Arthritis
Jawaharlal Institute of Postgraduate Medical Education & Research 136
Post-approval studies (Phase 4)Study completedNCT00563849
What this trial is testing

Leflunomide + Methotrexate in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sanofi 74
Not applicableUnknownNCT04384458
What this trial is testing

Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis

Who this might be right for
Coronavirus Infections
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara 400
Large-scale testing (Phase 3)Study completedNCT01808118
What this trial is testing

Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis

Who this might be right for
Axial Spondyloarthritis
AbbVie 673
Post-approval studies (Phase 4)Study completedNCT00828997
What this trial is testing

Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar®

Who this might be right for
Rheumatoid ArthritisSpondylarthropathy
Region Skane 505
Large-scale testing (Phase 3)Study completedNCT00503425
What this trial is testing

MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 215
Large-scale testing (Phase 3)Looking for participantsNCT04474847
What this trial is testing

Abatacept for the Treatment of Giant Cell Arteritis

Who this might be right for
Giant Cell Arteritis
University of Pennsylvania 78
Large-scale testing (Phase 3)Study completedNCT04334148
What this trial is testing

Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine

Who this might be right for
COVID-19
Adrian Hernandez 1,360
Not applicableStudy completedNCT01088321
What this trial is testing

Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 81,332
Not applicableUnknownNCT04201535
What this trial is testing

Identification of Novel Molecular Targets for Rheumatoid Arthritis Patients

Who this might be right for
Arthritis, RheumatoidBone Erosion
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 160
Not applicableStudy completedNCT02129595
What this trial is testing

Resveratrol and First-degree Relatives of Type 2 Diabetic Patients

Who this might be right for
Pre-diabetes
Maastricht University Medical Center 15
Not applicableStudy completedNCT01136694
What this trial is testing

Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs)

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 695
Not applicableUnknownNCT03440892
What this trial is testing

Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Vastra Gotaland Region 2,500
Large-scale testing (Phase 3)Study completedNCT02011334
What this trial is testing

A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 285
Large-scale testing (Phase 3)Active Not RecruitingNCT06276998
What this trial is testing

LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)

Who this might be right for
Rheumatoid Arthritis
Lynk Pharmaceuticals Co., Ltd 430
Testing effectiveness (Phase 2)Looking for participantsNCT07423533
What this trial is testing

Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD

Who this might be right for
Rheumatoid Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd. 450
Early research (Phase 1)Study completedNCT01137708
What this trial is testing

CP-690,550 And Oral Contraception Drug-Drug Interaction Study

Who this might be right for
Healthy
Pfizer 20
Not applicableStudy completedNCT02346942
What this trial is testing

Factors Associated With Biologic DMARD Switching

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 4,099
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation